News

In a letter to healthcare providers dated 11 July 2023, the US Food and Drug Administration (FDA) communicates that the risk of mortality associated with paclitaxel-coated devices to treat peripheral arterial disease (PAD) is no longer supported based on the totality of the available data and analyses.

Publikationen

Produktbroschüren

NiTiDES

Produktbroschüre

Cre8™ EVO

Produktbroschüre

Cre8 BTK

Produktbroschüre

Easy Flype

Produktbroschüre

Easy High Flype

Produktbroschüre

Radix2

Produktbroschüre

Isthmus Logic

Produktbroschüre

MagicTouch

Produktbroschüre

MagicTouch PTA

Produktbroschüre

MagicTouch AVF

Produktbroschüre

MagicTouch ED

Produktbroschüre

Abluminus DES+

Produktbroschüre

NiTiDES

Produktbroschüre

Cre8™ EVO

Produktbroschüre

Cre8 BTK

Produktbroschüre

Easy Flype

Produktbroschüre

Easy High Flype

Produktbroschüre

Radix2

Produktbroschüre

Isthmus Logic

Produktbroschüre

MagicTouch

Produktbroschüre

MagicTouch PTA

Produktbroschüre

MagicTouch AVF

Produktbroschüre

MagicTouch ED

Produktbroschüre

Abluminus DES+

Produktbroschüre

IFUs

NiTiDES

IFU (IRevision date is 05.2021)
IFU

Cre8™ EVO

IFU ( Revision date is 05.2022)
IFU

Cre8 BTK

IFU (Revision date is 04.2023)
IFU

Easy Flype

IFU (Revision date is 05.2021)
IFU

Easy High Flype

IFU (Revision date is 05.2021)
IFU

Radix2

IFU (Revision date is 11.2020)
IFU

Isthmus Logic

IFU (Revision date is 06.2019)
IFU

NiTiDES

IFU (IRevision date is 05.2021)
IFU

Cre8™ EVO

IFU ( Revision date is 05.2022)
IFU

Cre8 BTK

IFU (Revision date is 04.2023)
IFU

Easy Flype

IFU (Revision date is 05.2021)
IFU

Easy High Flype

IFU (Revision date is 05.2021)
IFU

Radix2

IFU (Revision date is 11.2020)
IFU

Isthmus Logic

IFU (Revision date is 06.2019)
IFU